ATF5 and primary cutaneous T-cell non-Hodgkin lymphoma: Our results showed that ATF5 promotes the activation of the PI3K/AKT/mTOR axis by regulating PIK3AP1, adding to the understanding of the regulation of this pathway in CTCL.